Search Results - "van der Wetering, M"

2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients by Roila, F, Molassiotis, A, Herrstedt, J, Aapro, M, Gralla, R J, Bruera, E, Clark-Snow, R A, Dupuis, L L, Einhorn, L H, Feyer, P, Hesketh, P J, Jordan, K, Olver, I, Rapoport, B L, Roscoe, J, Ruhlmann, C H, Walsh, D, Warr, D, van der Wetering, M

Get full text

The selective 5-HT6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment by de Bruin, N.M.W.J., van Loevezijn, A., Wicke, K.M., de Haan, M., Venhorst, J., Lange, J.H.M., de Groote, L., van der Neut, M.A.W., Prickaerts, J., Andriambeloson, E., Foley, A.G., van Drimmelen, M., van der Wetering, M., Kruse, C.G.

“…•SLV is a novel highly selective 5-HT6 antagonist.•SLV was studied in animal models for cognitive impairment and social interaction.•SLV was effective at 20…”
Get full text

The selective 5-HT 6 receptor antagonist SLV has putative cognitive- and social interaction enhancing properties in rodent models of cognitive impairment by de Bruin, N.M.W.J., van Loevezijn, A., Wicke, K.M., de Haan, M., Venhorst, J., Lange, J.H.M., de Groote, L., van der Neut, M.A.W., Prickaerts, J., Andriambeloson, E., Foley, A.G., van Drimmelen, M., van der Wetering, M., Kruse, C.G.

Get full text

Solution Structure of the Sequence-specific HMG Box of the Lymphocyte Transcriptional Activator Sox-4 (∗) by van Houte, Leo P.A., Chuprina, Vasily P., van der Wetering, Marc, Boelens, Rolf, Kaptein, Robert, Clevers, Hans

“…Two groups of HMG box proteins are distinguished. Proteins in the first group contain multiple HMG boxes, are non-sequence-specific, and recognize structural…”
Get full text